The Discounted Cash Flow (DCF) valuation of Rich Pharmaceuticals Inc (RCHA) is (0.10) USD. With the latest stock price at 0.00 USD, the upside of Rich Pharmaceuticals Inc based on DCF is -19747.2%.
Based on the latest price of 0.00 USD and our DCF valuation, Rich Pharmaceuticals Inc (RCHA) is a sell. selling RCHA stocks now will result in a potential gain of 19747.2%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 3.9% - 4.3% | 4.1% |
| Long-term Growth Rate | 2.0% - 3.7% | 2.8% |
| Fair Price | (0.48) - (0.06) | (0.10) |
| Upside | -97019.0% - -11504.4% | -19747.2% |